Key Trends Influencing the Growth of the Prostate Specific Antigen (PSA) Test Market in 2025: Technological Advancements Propel Innovation In The Prostate-Specific Antigen (PSA) Test Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Prostate Specific Antigen (PSA) Test Market Through 2025?
The market size for the Prostate Specific Antigen (PSA) test has seen a significant expansion in recent times. It is projected to increase from $4.15 billion in 2024 to $4.66 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.1%. Factors such as heightened awareness, an aging demographic, advancements in medical and pharmaceutical fields, along with clinical recommendations, are credited for the growth witnessed in the historic period.

What's the Projected Size of the Global Prostate Specific Antigen (PSA) Test Market by 2029?
The market size for the prostate specific antigen (PSA) test is projected to witness a swift expansion in the coming years, growing to $7.29 billion by 2029, with a compound annual growth rate (CAGR) of 11.9%. Factors contributing to this surge in the forecasted period include advancements in test precision, personalized medicine methodologies, and the worldwide increase in elderly population. The major trend shifts in this period will likely be towards combinations of biomarkers, technological innovation and evolution, point-of-care medical testing, integration of digital health, with a spotlight on early recognition and intervention.

View the full report here:
https://www.thebusinessresearchcompany.com/report/prostate-specific-antigen-psa-test-global-market-report

Top Growth Drivers in the Prostate Specific Antigen (PSA) Test Industry: What's Accelerating the Market?
The escalating occurrence of prostate cancer is anticipated to push the prostate-specific antigen (PSA) test market's growth. Prostate cancer arises in the prostate gland, a part of the reproductive systems in both men and women. The PSA test, which measures the level of PSA in the bloodstream, is a common screening tool for prostate cancer in men and can help in its early detection and risk assessment. For example, in March 2023, data from the American Society of Clinical Oncology (ASCO), a professional oncology group in the US, reported that roughly 288,300 men were diagnosed with prostate cancer and about 34,700 people died that same year. Thus, the rising prevalence of prostate cancer is promoting the growth of the PSA test market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12576&type=smp

What Trends Will Shape the Prostate Specific Antigen (PSA) Test Market Through 2029 and Beyond?
The rise in technological advancements is a notable trend spearheading the popularity in the prostate-specific antigen (PSA) test market. Notably, dominant companies in the PSA test industry are now engineering sophisticated screening test tools in a bid to maintain their market standing. For example, a diagnostic firm based in the US, LynxDx Inc., unveiled the MyProstateScore 2.0 in February 2023: a unique non-invasive urine screening test aimed at prostate cancer. This cutting-edge test leverages an array of 18 biomarkers, inclusive of the new gene fusion T2:ERG, to deliver a personalized risk evaluation for every patient. Furthermore, this screening test delivers highly accurate risk assessment insights that are stratified to guide clinical decisions in patients demonstrating elevated PSA results or abnormal findings from a digital rectal exam (DRE). Importantly, this screening test may potentially enhance the screening and treatment of prostate cancer.

What Are the Main Segments in the Prostate Specific Antigen (PSA) Test Market?
The prostate specific antigen (PSA) test market covered in this report is segmented -

1) By Type: Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types
2) By Application: Screening, Post-Treatment Monitoring, Other Applications
3) By End User: Hospitals, Diagnostic Centers, Research Institutes, Other End Users

Subsegments:
1) By Clinical Laboratory Improvement Amendments (CLIA): CLIA Waived Tests, Non-CLIA Tests
2) By Enzyme-Linked Immunosorbent Assay (ELISA): Sandwich ELISA Kits, Competitive ELISA Kits
3) By Fluorescence Immunoassay (FIA): Point-Of-Care FIA, Laboratory-Based FIA
4) By Other Types: Chemiluminescent Immunoassay (CLIA), Radioimmunoassay (RIA)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12576&type=smp

Which Top Companies are Driving Growth in the Prostate Specific Antigen (PSA) Test Market?
Major companies operating in the prostate specific antigen (PSA) test market include Siemens AG, F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Becton inson and Company, PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin SpA, OPKO Health Inc., R&D Systems Inc., Meso Scale Diagnostics LLC, Tosoh America Inc., Fujirebio Europe N.V., Boditech Med Inc., DRG International Inc., BioVision Inc., Enzo Life Sciences Inc., RayBiotech Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Elabscience, LifeSpan BioSciences Inc., American Laboratory Products Company Ltd., Accuquik Inc.

Which Regions Will Dominate the Prostate Specific Antigen (PSA) Test Market Through 2029?
North America was the largest region in the prostate specific antigen (PSA) test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate specific antigen (PSA) test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12576

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.